Agentix Corp.
Agentix Corp.
- Market cap
- $1.95M
Your view on AGTX
Overview
What the company does, where it operates, and who runs it.
About Agentix Corp.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Riazul Huda
- Headquarters
- 32932 Pacific Coast Highway, Dana Point, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Riazul Huda
- Headquarters
- 32932 Pacific Coast Highway, Dana Point, CA, US
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases.
Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases.
The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was incorporated in 2013 and is based in Dana Point, California.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Agentix Corp.. Starting points for Agentix Corp.: EPS -$0.0091, beta 0.81 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Agentix Corp.. Agentix Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Agentix Corp.. Trailing twelve-month EPS for Agentix Corp. stands at -$0.0091. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Agentix Corp.. Agentix Corp. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| ABTIAlterola Biotech, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $7.4M | ||
| ACBMAcro Biomedical Co., Ltd. | Healthcare | Medical - Pharmaceuticals | $1.3M | ||
| ACHFFArch Biopartners Inc. | Healthcare | Biotechnology | $41.0M | ||
| ADMTADM Tronics Unlimited, Inc. | Healthcare | Medical - Devices | $6.8M | ||
| ADTXAditxt, Inc. | Healthcare | Biotechnology | $498,988 | ||
| ADYXAdynxx, Inc. | Healthcare | Biotechnology | $581 | ||
| ARCTArcturus Therapeutics Holdings Inc. | Healthcare | Biotechnology | $214.7M | ||
| RVPHReviva Pharmaceuticals Holdings, Inc. | Healthcare | Biotechnology | $36.3M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PAR.AXParadigm Biopharmaceuticals Limited | Healthcare | ASX | — | ||
| PARDPoniard Pharmaceuticals, Inc. | Healthcare | OTC | $150 | ||
| PASGPassage Bio, Inc. | Healthcare | NASDAQ | $12.6M | ||
| PBIGFParadigm Biopharmaceuticals Limited | Healthcare | OTC | $87.9M | ||
| PBLAPanbela Therapeutics, Inc. | Healthcare | OTC | $53,889 | ||
| PBLSParabilis Medicines, Inc. | Healthcare | NASDAQ | $3.3B | ||
| PBMPsyence Biomedical Ltd. | Healthcare | NASDAQ | $56,486 | ||
| PBMWWPsyence Biomedical Ltd. Warrant | Healthcare | NASDAQ | $973 | ||
| PBYIPuma Biotechnology, Inc. | Healthcare | NASDAQ | $364.5M | ||
| PCSAProcessa Pharmaceuticals, Inc. | Healthcare | NASDAQ | $4.4M | ||
| PCVXVaxcyte, Inc. | Healthcare | NASDAQ | $8.8B | ||
| PDSBPDS Biotechnology Corporation | Healthcare | NASDAQ | $43.4M | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Agentix Corp. executives and directors. Shares of Agentix Corp. have traded between $0.02 and $0.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Agentix Corp.